정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2046 | Terminated | Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 | COVID-19 | Drug: Chloroquine Sulfate Drug: Hydroxychloroquine Other: Standard supportive care |
Phase 4 | UMC Utrecht, ZonMw: The Netherlands Organisation for Health Research and Development | OTHER | 25 | All | 18 Years ~ 110 Years | UMCU, Utrecht, Netherlands |
| 2045 | Recruiting | Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting | Acute Respiratory Illnesses | Drug: Chloroquine or Hydroxychloroquine Drug: Placebo |
Not Applicable | University of Oxford | OTHER | 40000 | All | 16 Years | Chattogram Medical College Hospital, Chittagong, Chattogram, Bangladesh Centre Hospitalier et Universitaire de Zone Abomey-Calavi, Abomey-Calavi, Benin Alert Hospital, Addis Ababa, Ethiopia The St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia Zewditu Memorial Hospital, Addis Ababa, Ethiopia Airlangga University Hospital (UNAIR), Surabaya, East Java, Indonesia Husada Utama Hospital, Surabaya, East Java, Indonesia Metropolitan Medical Care Hospital, Jakarta, Jakarta Selatan, Indonesia RSUPN Cipto Mangunkusumo Hospital, Jakarta Pusat, Jakarta, Indonesia Bunda Thamrin Hospital, Medan, North Sumatra, Indonesia Adam Malik Hospital, Medan, North Sumatra, Indonesia Murni Teguh Memorial Hospital, Medan, North Sumatra, Indonesia Dadi Hospital, Makassar, South Sulawesi, Indonesia Hasanuddin University Hospital (UNHAS), Makassar, South Sulawesi, Indonesia Wahidin Hospital, Makassar, South Sulawesi, Indonesia Sardjito Hospital, Yogyakarta, Indonesia Istituto Sacro Cuore Don Calabria, Negrar, Negrar Di Valpolicella VR, Italy Fountain Healthcare Hospital, Eldoret, Kenya Coast General Teaching and Referral Hospital, Mombasa, Kenya Mbagathi County Hospital, Nairobi, Kenya Mahosot hospital, Vientiane, Lao People's Democratic Republic Centre for Vaccine Development-Mali, Bamako, Mali Koshi Hospital, Biratnagar, Nepal B.P. Koirala Institute of Health Sciences, Dhar?n B?z?r, Nepal Niamey (Epicentre France), Maradi, Niger The Aga Khan University Hospital, Karachi, Pakistan Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand University Hospitals Of Morecambe Bay NHS Foundation Trust, Kendal, Cumbria, United Kingdom The Princess Alexandra Hospital NHS Trust, Harlow, Essex, United Kingdom Lewisham and Greenwich NHS Trust, Woolwich, London, United Kingdom The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom Northern devon healthcare NHS trust, Barnstaple, United Kingdom Birmingham & Solihull Mental Health NHS Trust, Birmingham, United Kingdom Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom Rotherham, Doncaster And South Humber NHS Foundation Trust, Doncaster, United Kingdom Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom Imperial College Healthcare NHS Trust, London, United Kingdom Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom Zambart, Lusaka, Zambia |
| 2044 | Completed | Cholecalciferol to Improve the Outcomes of COVID-19 Patients | COVID | Drug: Vitamin D Drug: Placebo |
Phase 4 | Vitamin D Study Group, Ag Nac Promocion de la Investigacion, el Desarrollo Tecnologico y la Innovacion | NETWORK | 218 | All | 18 Years | Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina |
| 2043 | Recruiting | Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability | Muscle | Other: Questionnaires Biological: blood test Other: Maximal effort test Device: actigraphy Device: Neuromuscular evaluation Other: stool analysis Other: food diary |
Not Applicable | Centre Hospitalier Universitaire de Saint Etienne, University of Saint-Etienne, Laboratoire des Adaptations Metaboliques a l'Exercice en conditions Physiologiques et Pathologiques | OTHER | 102 | All | 35 Years ~ 80 Years | CHU de Grenoble, Grenoble, France Clinique de la Sauvegarde - Lyon, Lyon, France Hopital Croix Rousse - HCL, Lyon, France Centre Hospitalier de Lyon Sud, Pierre-benite, France Chu Saint-Etienne, Saint Etienne, France Clinique Mutualiste Saint Etienne, Saint Etienne, France Hopital Henry Gabrielle, Saint-Genis-Laval, France Hopital prive de la Loire, Saint-Etienne, France |
| 2042 | Recruiting | ChulaCov19 Vaccine in Healthy Adults | Safety Issues | Biological: ChulaCov19 vaccine Other: Placebo |
Phase 2 | Chulalongkorn University, Chula Vaccine Research Center (ChulaVRC), Bangkok, Thailand, Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, Chula Clinical Research Center (Chula CRC), King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, King Chulalongkorn Memorial Hospital (KCMH), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, National Vaccine Institute (NVI), Thailand | OTHER | 222 | All | 18 Years ~ 75 Years | Chula Vaccine Research Center (ChulaCRC) Faculty of Medicine Chulalongkorn University, Bangkok, Thailand Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine Mahidol University, Bangkok, Thailand |
| 2041 | Completed | Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection | Covid19 | Drug: Clarithromycin 500mg Drug: Azithromycin Drug: Placebo |
Not Applicable | South Valley University | OTHER | 300 | All | 18 Years | south-Vally University faculty of medicine, Qena, Egypt |
| 2040 | Active, not recruiting | Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease | COVID19 | Drug: Clazakizumab | Phase 2 | Cedars-Sinai Medical Center | OTHER | 17 | All | 18 Years ~ 100 Years | Cedars-Sinai Medical Center, Los Angeles, California, United States |
